MGX Q1 2026 Earnings Missed Expectations as PreRevenue Biotech Advances Gene Editing Pipeline KNOT Offshore Partners Q4 2025 Earnings Significant Earnings Miss Highlights Operational Challenges GBLI Q1 2026 Earnings Significant EPS Miss Underscores Underwriting Challenges ADAMM Q1 2026 Earnings Strong EPS Beat Driven by Investment Income FENG Q3 2024 Earnings Net Loss Deepens as Advertising Headwinds Persist GeneDx Holdings Warrants Rally 1477 From Penny Level Yet Resistance Remains Stubborn Vuzix Corporation VUZI Surges 9 as Stock Tests Key Resistance at 540 Community Healthcare Trust CHCT Slides 19 Amid Ongoing Sector Headwinds LQR House Inc YHC Edges Higher Amid Consolidation at 086 Support and Resistance Remain Key CELH Q1 2026 Earnings Strong EPS Beat Signals Profitability Improvement